Skip to main content
. 2012 Apr 11;5:35–42. doi: 10.2147/CEG.S30281

Figure 2.

Figure 2

(A) Focal DCLK1 immunoreactivity in a moderately differentiated adenocarcinoma (200×). (B) Diffuse DCLK1 immunoreactivity in a moderately differentiated adenocarcinoma (100×).

Abbreviation: DCLK1, doublecortin and CaM kinase-like-1.